Show simple item record

dc.creatorApostolidou, E.en
dc.creatorXatzoglou, C.en
dc.description.abstractThe use of peritoneal dialysis for patients with end stage renal disease is not widespread, mainly because of the complications of repeated peritoneal dialysis, such as peritonitis and peritoneal fibrosis. Leptin is a 16 kDa hormone whose basic function is the maintenance of body weight and the balance of energy expenditure. Evidence for the involvement of leptin in the complications of peritoneal dialysis, i.e., peritonitis and peritoneal fibrosis, is increasing. It appears that leptin could be used as a prognostic or diagnostic tool for the early diagnosis of peritonitis. Leptin also acts synergistically with TGF-β and enhances the progress of fibrosis. Drugs that antagonize the action of leptin could possibly be developed for the inhibition or modulation of the progress of fibrosis. Further studies on this issue are anticipated, as leptin appears to be a hormone with much promise for the clinician. © Athens Medical Society.en
dc.sourceArchives of Hellenic Medicineen
dc.subjectPeritoneal dialysisen
dc.subjectPeritoneal fibrosisen
dc.subjectPeritoneal permeabilityen
dc.subjecttransforming growth factor betaen
dc.subjectbody weighten
dc.subjectdisease courseen
dc.subjectenergy balanceen
dc.subjectkidney failureen
dc.subjectrepeat procedureen
dc.titleComplications of chronic peritoneal dialysis: The role of leptinen

Files in this item


There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record